Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Intrum in connection with several financing transactions (1)
Mandate

Vinge advises Intrum in connection with several financing transactions

September 20, 2019 Banking and Finance

Vinge has advised Intrum AB (publ) in connection with several financing transactions during the third quarter of 2019.

Intrum issued notes in the amount of 750 MEUR in July  and 850 MEUR in September and entered into a 2,000 MSEK backup credit facility agreement with Nordic banks in July 2019. Vinge has advised Intrum as to matters of Swedish law in relation to all transactions. 

Vinge’s team consisted of amongst others Louise Brorsson Salomon, Josefine Larsson, Pauline Lagerstrand, Jolinn Uhlin and Anders Sundin Lundberg.

Related

Vinge advises Trianon in connection with directed share issue and tender offer for subordinated sustainable capital securities

 Vinge advises Fastighets Aktiebolaget Trianon (publ) in connection with a directed share issue of SEK 184 million and a tender offer for outstanding subordinated perpetual floating rate callable sustainable capital securities.
April 19, 2024

Vinge advises Blackstone in connection with its investment in Winthrop Technologies

 Vinge, as local Swedish counsel, advised Blackstone Tactical Opportunities and affiliated funds (“Blackstone”) in connection with a strategic partnership with Winthrop Technologies Limited (“Winthrop Technologies”).
April 17, 2024

Vinge has advised Hansa Biopharma in connection with a directed share issue of SEK 372 million

 Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue through which the company raises proceeds of SEK 372 million before transaction costs. Hansa Biopharma is a commercial-stage biopharmaceutical company pioneering the development and commercialization of innovative, lifesaving and life altering treatments for patients with rare immunological conditions. Hansa Biopharma’s ordinary share is listed on Nasdaq Stockholm.
April 16, 2024